Redefined indications for subcutaneous mastectomy in patients with benign breast disease.
The indications for subcutaneous mastectomy have been redefined as a result of more recent and more conclusive data. This information has provided us with specific biological markers that define more clearly the high-risk woman for breast cancer. Proliferative disease, with and without atypia, should replace the previous criterion of moderate to severe fibrocystic disease or non-specific mammary dysplasia.
D001706:Biopsy; D001940:Breast / Q000473:pathology; D001941:Breast Diseases / Q000601:surgery*; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control; D005260:Female; D006801:Humans; D008327:Mammography; D008408:Mastectomy / Q000379:methods / Q000706:statistics & numerical data*; D012306:Risk